Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - Goette, A; Merino, J L; Ezekowitz, M D; ENSURE-AF investigators (Lancet, 2016)
(10055):